Monopar Therapeutics: A Speculative Buy On 2 Fronts With Catalysts Imminent

If you are interested in keeping up to date with stocks making moves within the biotech, pharma, and healthcare industries and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?This is my first time covering Monopar Therapeutics Inc. (NASDAQ: MNPR ) for Seeking Alpha—first, let's consider a business overview provided by the company in its Q2 2025The group is for both novice and experience ...